ABCL
Price
$2.31
Change
+$0.17 (+7.94%)
Updated
Jun 3 closing price
Capitalization
689.5M
69 days until earnings call
PRAX
Price
$41.23
Change
+$1.41 (+3.54%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
811.09M
76 days until earnings call
Interact to see
Advertisement

ABCL vs PRAX

Header iconABCL vs PRAX Comparison
Open Charts ABCL vs PRAXBanner chart's image
AbCellera Biologics
Price$2.31
Change+$0.17 (+7.94%)
Volume$5.01M
Capitalization689.5M
Praxis Precision Medicines
Price$41.23
Change+$1.41 (+3.54%)
Volume$3.54K
Capitalization811.09M
ABCL vs PRAX Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRAX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABCL: $2.31 vs. PRAX: $41.20)
Brand notoriety: ABCL and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 124% vs. PRAX: 56%
Market capitalization -- ABCL: $689.5M vs. PRAX: $811.09M
ABCL [@Biotechnology] is valued at $689.5M. PRAX’s [@Biotechnology] market capitalization is $811.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while PRAX’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • PRAX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +16.67% price change this week, while PRAX (@Biotechnology) price change was +14.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

PRAX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($811M) has a higher market cap than ABCL($689M). ABCL YTD gains are higher at: -21.160 vs. PRAX (-46.466). ABCL has higher annual earnings (EBITDA): -211.2M vs. PRAX (-232.71M). ABCL has more cash in the bank: 605M vs. PRAX (328M). PRAX has less debt than ABCL: PRAX (1.07M) vs ABCL (67.8M). ABCL has higher revenues than PRAX: ABCL (23.1M) vs PRAX (8.12M).
ABCLPRAXABCL / PRAX
Capitalization689M811M85%
EBITDA-211.2M-232.71M91%
Gain YTD-21.160-46.46646%
P/E RatioN/AN/A-
Revenue23.1M8.12M284%
Total Cash605M328M184%
Total Debt67.8M1.07M6,360%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPRAX
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QUERX21.370.02
+0.09%
AQR Large Cap Defensive Style R6
CFVLX31.99N/A
N/A
Commerce Value
FBSRX34.73N/A
N/A
Franklin Mutual U.S. Mid Cap Value R
VPCCX34.14N/A
N/A
Vanguard PRIMECAP Core Inv
SEWIX16.59N/A
N/A
NAA World Equity Income Instl

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+7.94%
CRSP - ABCL
63%
Loosely correlated
+2.95%
ABSI - ABCL
59%
Loosely correlated
+1.83%
BEAM - ABCL
58%
Loosely correlated
+4.26%
RXRX - ABCL
58%
Loosely correlated
+0.46%
VCYT - ABCL
56%
Loosely correlated
-0.90%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+3.47%
CDXS - PRAX
48%
Loosely correlated
+4.00%
MNMD - PRAX
44%
Loosely correlated
+2.81%
ABCL - PRAX
43%
Loosely correlated
+7.94%
DNLI - PRAX
43%
Loosely correlated
-0.21%
XENE - PRAX
39%
Loosely correlated
+2.16%
More